Your browser doesn't support javascript.
loading
Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma.
Zhu, Ying; Ke, Kun-Bin; Xia, Zhong-Kun; Li, Hong-Jian; Su, Rong; Dong, Chao; Zhou, Feng-Mei; Wang, Lin; Chen, Rong; Wu, Shi-Guo; Zhao, Hui; Gu, Peng; Leung, Kwong-Sak; Wong, Man-Hon; Lu, Gang; Zhang, Jian-Ying; Jiang, Bing-Hua; Qiu, Jian-Ge; Shi, Xi-Nan; Lin, Marie Chia-Mi.
Afiliação
  • Zhu Y; Biomedical Engineering Research Center, Kunming Medical University, Kunming, 650500, Yunnan, China.
  • Ke KB; Department of Cadre Medical Branch, The 3rd Affiliated Hospital of Kunming Medical University, Kunming, 650118, Yunnan, China.
  • Xia ZK; Department of Urology, The 1st Affiliated Hospital of Kunming Medical University, Kunming, 650000, China.
  • Li HJ; Academy of Medical Science, Zhengzhou University, Zhengzhou, 450000, Henan, China.
  • Su R; CUHK-SDU Joint Laboratory On Reproductive Genetics, School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China.
  • Dong C; Department of Geriatric Cardiology, The 1st Affiliated Hospital of Kunming Medical University, Kunming, 650000, China.
  • Zhou FM; Department of the Second Medical Oncology, The 3rd Affiliated Hospital of Kunming Medical University, Yunnan Tumor Hospital, Kunming, 650000, China.
  • Wang L; Academy of Medical Science, Zhengzhou University, Zhengzhou, 450000, Henan, China.
  • Chen R; Academy of Medical Science, Zhengzhou University, Zhengzhou, 450000, Henan, China.
  • Wu SG; Department of Physiology, Yunnan University of Chinese Medicine, Kunming, 650504, Yunnan, China.
  • Zhao H; Department of Teaching and Research of Formulas of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming, 650000, Yunnan, China.
  • Gu P; Department of Urology, The 1st Affiliated Hospital of Kunming Medical University, Kunming, 650000, China.
  • Leung KS; Department of Urology, The 1st Affiliated Hospital of Kunming Medical University, Kunming, 650000, China.
  • Wong MH; Department of Computer Science and Engineering, The Chinese University of Hong Kong, Hong Kong, 999077, China.
  • Lu G; Department of Computer Science and Engineering, The Chinese University of Hong Kong, Hong Kong, 999077, China.
  • Zhang JY; CUHK-SDU Joint Laboratory On Reproductive Genetics, School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China.
  • Jiang BH; Academy of Medical Science, Zhengzhou University, Zhengzhou, 450000, Henan, China.
  • Qiu JG; Academy of Medical Science, Zhengzhou University, Zhengzhou, 450000, Henan, China.
  • Shi XN; Academy of Medical Science, Zhengzhou University, Zhengzhou, 450000, Henan, China.
  • Lin MC; Department of Pathology, Yunnan University of Chinese Medicine, Kunming, 650504, Yunnan, China. xilancixiang@163.com.
Mol Med ; 27(1): 15, 2021 02 12.
Article em En | MEDLINE | ID: mdl-33579185
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Carcinoma Hepatocelular / Quinase 2 Dependente de Ciclina / Quinase 4 Dependente de Ciclina / Quinase 6 Dependente de Ciclina / Fluoruracila / Neoplasias Hepáticas Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Carcinoma Hepatocelular / Quinase 2 Dependente de Ciclina / Quinase 4 Dependente de Ciclina / Quinase 6 Dependente de Ciclina / Fluoruracila / Neoplasias Hepáticas Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article